Back to Blog

#DineIn4GICI

Hold a Dine In for GICI Host a Dine In the way you want! Breakfast, Lunch, Dinner, Picnic, BBQ Ask your friends, family, community or clubs  We provide a pack with tips on how to run a Dine In and a sample invitation  Register your Dine In for GICI here Every host receives an ECOYA candle...

Research Update

GICI Clinical Trial published in the Journal of Clinical Oncology. The results are extremely promising for patients with cancer of the stomach and oesophagus/stomach junction where chemotherapy has failed and there are no other approved treatment options. For more information click here...

Announcement!

Subject title: GICI NZ: Call for Expression of Interest for GI Cancer Clinical Research The GI Cancer Institute NZ provides annual funding opportunities for clinical research to improve the quality of life and survival for people living with a GI cancer. Applications are open to appropriately qualified individuals with New Zealand residency, permanent residency or citizenship, who hold a relevant degree or are in the process of completing their training.  This expression of interest is open...

Announcement!

GI Cancer Clinical Research Fellowship Subject title: GICI NZ: Call for Applications – Part time 0.3-0.5 FTE GI Cancer Clinical Research FellowshipThe GI Cancer Institute NZ is calling for applications for:Part time GI Cancer Clinical Fellowship The GI Cancer Institute NZ offers one part time 0.3-0.5 FTE GI Cancer Clinical Research Fellowship award each year supported by the Hugh Green Foundation. The Fellowship is for the support of outstanding graduates from all relevant health professions,...

Patron for GICI NZ

Dame Rosie Horton joins GICI NZ as our Patron. We are delighted to have Dame Rosie on board as she brings a wealth of experience in the not for profit sector. Dame Rosemary Horton DNZM QSO QSM is a philanthropist and mentor for New Zealand charities. Founding Chairman of the following: Friends of Aotea Trust, The Aotea Centre Performing Arts Trust,  Friends of Starship and Trustee of the Starship Foundation.  Chairman of NZ Breast Cancer Foundation and Chairman or Trustee of numer...

Awareness Campaign Report

Thanks to all of you who supported our latest Awareness Campaign strategy. In particular thanks to Kelliher Trust for hosting the launch of the new brand, Novartis for the new pamphlet design and distribution, Perpetual Guardian and the Hugh Green Foundation for grants to make the promotion happen. We accessed approximately 200,000 people through facebook, raised $30,000 over the three months and has $22,000 of free promotion. Many of you saw the promotion and thanks for feedback. Our Dine In fo...

Dine In for GICI

Help raise funds to support GICI with vital clinical research to improve survival! Host a Dine In the way you want! Breakfast, Lunch, Dinner, Picnic, BBQ Ask your friends, family, community or club We provide a pack with tips on how to run a Dine In and a sample invitation Register your Dine In for GICI today  info@gutcancer.org.nz Every host receives an ECOYA candle...

Meet the Experts: Register here

Meet the Experts is your chance to meet the specialists including Professor Michael Findlay, Oncologist; Mr Arend Merrie, lower GI tract surgeon; Mr Grant Beban, upper GI tract surgeon; and a nutritionist to be confirmed. May 19th 6.30pm to 9.30pm Light refreshments provided This is a free event, however donations are always welcome. Thanks to Harold Watson fund through Perpetual Guardian. RSVP info@gutcancer.org.nz or ph 0800 112 775  Venue: Junior School Hall, Diocesan School for Girls, E...

Text to Donate

Text GICI to 2449 to donate $3. Every dollar helps....

I was one of 5,000!

Successful businessman of Trilogy and Moa beer Grant Baker (The Bakery) tells us how having money doesn’t always discriminate. About ten years ago, I was feeling very comfortable in my position as Executive Chairman of 42 Below Ltd, a vodka and gin producer that had just been recognised by Deloitte as New Zealand’s fastest growing business. Family life was good and I had regularly been fuelling my passion for motor racing. My only problem was that I had started to experience some pretty bad ...

These people showed us their guts!

The stomach is quite a personal part of the body, wouldn’t you agree?  Not many of us would bare it, but these guys did, they got #GutsyForGici. GICI (said Giki) is daring you to show your guts – by writing a message on your stomach, large or small, hairy or not! about gastro-intestinal cancers statistics and the hashtag #GutsyForGici. They will keep an eye out for the best ones and reward them with prizes even....

Awareness Campaign Launch

GICI Awareness Campaign brand launched on March 16th. Supporters of GICI heard about the high rate of GI cancers and the reality that over half of people diagnosed will die within five years. Thanks to Kelliher Trust for hosting the evening, Perpetual Guardian Trust, the Hugh Green Foundation and Novartis for assisting with funding to make this all happen. Help us Kick Cancer in the Guts by supporting our new campaign adn funding vital clinical research trials. #‎GutsyforGICI‬...

Text GICI to 2449

Text GICI to 2449 to donate $3 or www.gutcancer.org.nz/donate. Help us fund vital clinical research for this under funded disease and save lives!...

GICI launches new Awareness Campaign!

On March 16th GICI launched a new Awareness Campaign brand profiling the high rates of GI cancers in New Zealand. 5,000 people a year are diagnosed with over half dying within 5 years. We fund vital clinical research to improve this rate and we are making a difference with the mortality rate dropping 3% between 2011 and 2012. Help us, share this video, ‪#‎GutsyforGICI‬ To donate $3 TEXT GICI to 2449 or www.gutcancer.org.nz/donate https://www.youtube.com/watch?v=FOgiJFQuUYw...

INTEGRATE Research Trial Update

The INTEGRATE Trial is helping answer an important health question. It has provided evidence that a new treatment, regorafenib, acts against advanced oesophago-gastric cancer and is safe. The investigators are now confident that they can look into a larger trial investigating survival. The trial recruited 152 patients from Australia, New Zealand, Korea and Canada. Patients were randomly allocated to regorafenib or a placebo tablet. Two thirds of the participants were put on the trial drug. All h...

Ministry of Health Cancer Statistics 2012

The latest Ministry of Health cancer statistics are now available. The death rate for gastro-intestinal cancers has dropped from 59% to 56%. Pancreatic cancer death rate has dropped the most from 94% to 84% in the last year. Men have considerably higher rates of GI cancers. GI cancers account for 22.5% of all cancers and 30.8% of all deaths from cancer. Help us raise funds to fight this disease. Text GICI to 2449 to donate $3 or www.gutcancer.org.nz/donate....

Update

CONTROL NETsThis study has opened in Australia for patients with advanced low or intermediate grade neuroendocrine tumours (NETs). These are uncommon tumours in the gastrointestinal tract which occur particularly in the pancreas or the midgut. Those from each site will be studied separately within the study. In Australia patients may be treated with PRRT, which involves giving a radioactive compound by vein which then targets onto the tumour cells. In the study, for the midgut NETs, they will co...

Thank you Iris Franks

A huge Thank You to Iris Franks and her family who raised $3,850 through their Santa House for GICI. A great effort and a great way to start 2016....

Run for GICI

Join the Gut Buster team on Everyday Hero and raise money for GICI NZ! Gather your friends, family, work colleagues and join us on March 6th. The first 20 people receive a Gut Buster tee shirt. Start training this summer! To join the team click here....

Neuroendocrine Tumour Group estabished

Neuroendocrine Tumour Group Established!Representatives from Australia, New Zealand and Canada met for the first major project of the Commonwealth Neuroendocrine Tumour Group (CommNETS). This collaborative two day meeting was a result of discussions at several international conferences between the organising committee members about the need for countries with common interests, such as Australia, New Zealand and Canada, to unite to address issues in research and treatment of patients with Neuroen...

New Director Gavin Gerrard joins GICI NZ

Gavin Gerrard joins GICI as a director. Gavin Gerrard is a survivor of oesophagus cancer, successfully operated on by Grant Beban. Gavin's background is construction in residential, industrial, commercial and land sub-division. He is currently chairperson of a large building industry manufacturing company of which he owns 50%. Over the last 10 years he has been a mentor for NZ Business Mentors. He is also an avid yacht person and has competed internationally including world championships....

ASCOLT Study

This study is the first to evaluate aspirin as adjuvant therapy in established cancers, and has been tipped as one of the most important gastrointestinal cancer studies globally.  In 2012, the National Cancer Institute of U.S listed aspirin’s role in cancer as one of the most provocative questions in cancer research. The AGITG has also recently ranked “Aspirin in Colorectal Cancer” – as the top research priority in gastrointestinal cancer, and has therefore committed to recruiting f...

A La Cart Research Update

A La Cart Research UpdateGICI was pleased to be able to support New Zealand participation in the Australasian Laparoscopic Cancer of the Rectum Trial (ALaCaRT), which compared laparoscopic assisted (or keyhole surgery) with conventional open surgery for the treatment of rectal cancer. The study enrolled 475 patients from Australia and New Zealand and recently reported the preliminary findings based on an assessment of the adequacy or completeness of removal of the cancer. JAMA article click here...

SCOT update

Patients who are diagnosed with early bowel cancer may be advised to have chemotherapy treatment for 24 weeks after surgery. This treatment increases their chances of surviving the cancer.  Unfortunately, all chemotherapy treatments have side effects and these side effects often get worse as the treatment goes on.  Previous studies have demonstrated that a shorter course of chemotherapy may be less toxic without being less effective. The aim of the SCOT trial is to definitively answer ...

Bowel Screening Pilot

This is the Ministry of Health website and contains links to an update session held in August to discuss the results to date from the Waitemata DHB pilot screening programme, and plans for national roll out. The Ministry of Health are currently consulting the health sector and other agencies in order to set the groundwork for a national roll out of bowel cancer screening. The link contains a number of informative and downloadable presentatio...